Cargando…

A cell cycle–related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma

The cell cycle plays a vital role in tumorigenesis and progression. Long non-coding RNAs (lncRNAs) are key regulators of cell cycle processes. Therefore, understanding cell cycle–related lncRNAs (CCR-lncRNAs) is crucial for determining the prognosis of papillary thyroid carcinoma (PTC). RNA-seq and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuang, Ran, Ming-Yu, Qiao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009218/ https://www.ncbi.nlm.nih.gov/pubmed/36923215 http://dx.doi.org/10.3389/fendo.2023.1110987

Ejemplares similares

Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma
por: Wu, Mengwei, et al.
Publicado: (2019)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
por: Liu, Rui, et al.
Publicado: (2023)

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature
por: You, Xin, et al.
Publicado: (2018)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression
por: Yan, Ting, et al.
Publicado: (2021)

Advances on circRNAs Contribute to Carcinogenesis and Progression in Papillary Thyroid Carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2021)

Editorial: Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors
por: Volpi, Erivelto Martinho, et al.
Publicado: (2023)

Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma
por: Zhu, Hui, et al.
Publicado: (2016)

Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma
por: Siraj, Abdul K., et al.
Publicado: (2022)

Mouse Models of Follicular and Papillary Thyroid Cancer Progression
por: Russo, Marika A., et al.
Publicado: (2012)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

Appropriate Frequency and Interval of Neck Ultrasonography Surveillance during the First 10 Years after Total Thyroidectomy in Patients with Papillary Thyroid Carcinoma
por: Lee, Yoo Jin, et al.
Publicado: (2018)

LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p
por: Zhang, Hong, et al.
Publicado: (2018)

Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma
por: Li, Li, et al.
Publicado: (2021)

Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes
por: Baek, Hye Jin, et al.
Publicado: (2018)

Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer
por: Li, Chengxin, et al.
Publicado: (2023)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
por: Hao, Jie, et al.
Publicado: (2023)

Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients
por: Zhang, Dongxue, et al.
Publicado: (2017)

The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer
por: Xia, Minqi, et al.
Publicado: (2023)

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022)

Risk factors and diagnostic prediction models for papillary thyroid carcinoma
por: Zhang, Xiaowen, et al.
Publicado: (2022)

Relationship between serum NDRG3 and papillary thyroid carcinoma
por: Wang, Jiahao, et al.
Publicado: (2022)

Case Report: Papillary thyroid carcinoma in Goltz–Gorlin syndrome
por: Costanza, Flavia, et al.
Publicado: (2023)

Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma
por: Dolci, Alessia, et al.
Publicado: (2019)

Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
por: Hellmann, Andrzej, et al.
Publicado: (2023)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma
por: Mai, Shijie, et al.
Publicado: (2022)

Duration of Parathyroid Function Recovery in Patients With Protracted Hypoparathyroidism After Total Thyroidectomy for Papillary Thyroid Carcinoma
por: Qiu, Yuxuan, et al.
Publicado: (2021)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma
por: Shen, Yanyan, et al.
Publicado: (2018)

The Impact of Coexistent Hashimoto’s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Value of Contrast-Enhanced Ultrasound in Partially Cystic Papillary Thyroid Carcinomas
por: Fang, Fengkai, et al.
Publicado: (2021)

Pathology confirmation of the efficacy and safety of microwave ablation in papillary thyroid carcinoma
por: Ding, Min, et al.
Publicado: (2022)

Editorial: Recent advances in papillary thyroid carcinoma: Lymph node metastasis
por: Carrillo, Jose Federico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tunhjc596rhv10ufvqnmmej4qn